Neurokinin-1 receptor antagonists block acute cocaine-induced horizontal locomotion

Annals of the New York Academy of Sciences

Volumn 937, Issue , 2001, Pages 132-139

  Kraft, Madelyne ^a   Ahluwahlia, Sonia ^a   Angulo, Jesus A ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Cocaine; Neurokinin; NK 1 Receptor; Striatum; Substance P

Indexed keywords

3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; COCAINE; DRUG VEHICLE; LY 306740; NEUROKININ 1 RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; DRUG DELIVERY SYSTEM; DRUG EXPOSURE; HYPERACTIVITY; LOCOMOTION; MALE; NONHUMAN; OSMOTIC MINIPUMP; RAT;

ANIMALIA;

EID: 0034973466     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03562.x     Document Type: Conference Paper

References (29)

1. Inhibition as a basic process in the expression of striatal functions
2. Integration of Motor Functions in the Basal Ganglia
3. The neostriatal mosaic: Multiple levels of compartmental organization in the basal ganglia
4. Basal ganglia
5. Progressive augmentation of preprotachykinin mRNA levels in the striatum and nucleus accumbens of the rat: Repeated treatment with methamphetamine and effect of concurrent treatment with the N-methyl-D-aspartate receptor antagonist MK-801
6. Repeated administration of cocaine, nicotine and ethanol: Effects on preprodynorphin, preprotachykinin A and preproenkephalin mRNA expression in the dorsal and the ventral striatum of the rat
7. Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues
8. Influence of a single injection of cocaine, amphetamine or GBR12909 on mRNA expression of striatal neuropeptides
9. Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A
10. Substance P release from rat nucleus accumbens and striatum: An in viva study using antibody microprobes
11. Tachykinins: Receptor to effector
12. Actions of substance P on rat neostriatal neurons in vitro
13. Substance P (neurokinin-1) receptor mRNA is selectively expressed in cholinergic neurons in the striatum and basal forebrain
14. Pharmacological characterization of tachykinin receptors controlling acetylcholine release from rat striatum: An in viva microdialysis study
15. Substance P increases release of acetylcholine in the dorsal striatum of freely moving rats
16. Neurokinin receptors differentially mediate endogenous acetylcholine release evoked by tachykinins in the neostriatum
17. Substance P-(l-7) and substance P-(5-11) locally modulate dopamine release in rat striatum
18. Distinct presynaptic control of dopamine release in striosomal- and matrix-enriched areas of the rat striatum by selective agonists of NK1, NK2, and NK3 tachykinin receptors
19. Modulatory functions of neurotransmitters in the striatum:ACh/dopamine/NMDA interactions
20. Localization of striatal and nigral tachykinin receptors in the rat
21. Quantitation, cellular localization and regulation of neurokinin receptor gene expression within the rat substantia nigra
22. Substance P in the ventral pallidum: Projection from the ventral striatum, and electrophysiological and behavioral consequences of pallidal substance P
23. Localization of tachykinin binding sites (NK1, NK2, NK3 ligands) in the rat brain
24. Behavioral analysis of the effect of substance P injected into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat
25. Psychostimulant drugs and a dopamine hypothesis regarding addiction: Update on recent research
26. Acute and subchronic effects of dopamine agonists on neuropeptide gene expression in the rat striatum
27. Substance K and substance P in the ventral tegmental area
28. Efferent connections of the habenular nuclei in the rat
29. The origin of substance P and acetylcholine projections to the ventral tegmental area and interpeduncular nucleus in the rat